ICYMI: Company Announces Halt of Fibrodysplasia Ossificans Progressiva Clinical Development Program
source: pixabay.com

ICYMI: Company Announces Halt of Fibrodysplasia Ossificans Progressiva Clinical Development Program

According to a story from newswiretoday.com, the biopharmaceutical group Ipsen has recently announced its decision to halt its dosing of patients in its phase 3 clinical trial and its phase…

Continue Reading ICYMI: Company Announces Halt of Fibrodysplasia Ossificans Progressiva Clinical Development Program
Close Menu